Atrial Fibrillation Drugs Market (By Product: Antiarrhythmic Drugs, Anticoagulant Drugs; By Type: Paroxysmal, Permanent, Persistent; By Application: Heart Rate Control, Heart Rhythm Control; By Route Of Administration: Injectable, Oral; By End Use: Cardiac Centres, Hospitals, Ambulatory Surgical Centres) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Atrial Fibrillation Drugs
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Atrial Fibrillation Drugs Market By Product
                 1.2.2.1. Global Atrial Fibrillation Drugs Market Revenue and Growth Rate Comparison By Product (2015-2026)
                 1.2.2.2. Global Atrial Fibrillation Drugs Market Revenue Share By Product in 2017
                 1.2.2.3. Antiarrhythmic Drugs
                 1.2.2.4. Anticoagulant Drugs
       1.2.3. Atrial Fibrillation Drugs Market By Type
                 1.2.3.1. Global Atrial Fibrillation Drugs Market Revenue and Growth Rate Comparison By Type (2015-2026)
                 1.2.3.2. Global Atrial Fibrillation Drugs Market Revenue Share By Type in 2017
                 1.2.3.3. Paroxysmal
                 1.2.3.4. Permanent
                 1.2.3.5. Persistent
       1.2.4. Atrial Fibrillation Drugs Market By Application
                 1.2.4.1. Global Atrial Fibrillation Drugs Market Revenue and Growth Rate Comparison By Application (2015-2026)
                 1.2.4.2. Global Atrial Fibrillation Drugs Market Revenue Share By Application in 2017
                 1.2.4.3. Heart Rate Control
                 1.2.4.4. Heart Rhythm Control
       1.2.5. Atrial Fibrillation Drugs Market By Route Of Administration
                 1.2.5.1. Global Atrial Fibrillation Drugs Market Revenue and Growth Rate Comparison By Route Of Administration (2015-2026)
                 1.2.5.2. Global Atrial Fibrillation Drugs Market Revenue Share By Route Of Administration in 2017
                 1.2.5.3. Injectable
                 1.2.5.4. Oral
       1.2.6. Atrial Fibrillation Drugs Market By End Use
                 1.2.6.1. Global Atrial Fibrillation Drugs Market Revenue and Growth Rate Comparison By End Use (2015-2026)
                 1.2.6.2. Global Atrial Fibrillation Drugs Market Revenue Share By End Use in 2017
                 1.2.6.3. Cardiac Centres
                 1.2.6.4. Hospitals
                 1.2.6.5. Ambulatory Surgical Centres
       1.2.7. Atrial Fibrillation Drugs Market by Geography
                 1.2.7.1. Global Atrial Fibrillation Drugs Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.7.2. North America Atrial Fibrillation Drugs Market Revenue and Growth Rate (2015-2026)
                 1.2.7.3. Europe Atrial Fibrillation Drugs Market Revenue and Growth Rate (2015-2026)
                 1.2.7.4. Asia-Pacific Atrial Fibrillation Drugs Market Revenue and Growth Rate (2015-2026)
                 1.2.7.5. Latin America Atrial Fibrillation Drugs Market Revenue and Growth Rate (2015-2026)
                 1.2.7.6. Middle East and Africa (MEA) Atrial Fibrillation Drugs Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Atrial Fibrillation Drugs Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Atrial Fibrillation Drugs Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Atrial Fibrillation Drugs Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Atrial Fibrillation Drugs Major Manufacturers in 2017

CHAPTER 4. ATRIAL FIBRILLATION DRUGS MARKET BY PRODUCT

4.1. Global Atrial Fibrillation Drugs Revenue By Product
4.2. Antiarrhythmic Drugs
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Anticoagulant Drugs
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ATRIAL FIBRILLATION DRUGS MARKET BY TYPE

5.1. Global Atrial Fibrillation Drugs Revenue By Type
5.2. Paroxysmal
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Permanent
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Persistent
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ATRIAL FIBRILLATION DRUGS MARKET BY APPLICATION

6.1. Global Atrial Fibrillation Drugs Revenue By Application
6.2. Heart Rate Control
       6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Heart Rhythm Control
       6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. ATRIAL FIBRILLATION DRUGS MARKET BY ROUTE OF ADMINISTRATION

7.1. Global Atrial Fibrillation Drugs Revenue By Route Of Administration
7.2. Injectable
       7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Oral
       7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. ATRIAL FIBRILLATION DRUGS MARKET BY END USE

8.1. Global Atrial Fibrillation Drugs Revenue By End Use
8.2. Cardiac Centres
       8.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       8.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.3. Hospitals
       8.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.4. Ambulatory Surgical Centres
       8.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 9. NORTH AMERICA ATRIAL FIBRILLATION DRUGS MARKET BY COUNTRY

9.1. North America Atrial Fibrillation Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. North America Atrial Fibrillation Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. U.S.
       9.3.1. U.S. Atrial Fibrillation Drugs Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4. Canada
       9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5. Mexico
       9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 10. EUROPE ATRIAL FIBRILLATION DRUGS MARKET BY COUNTRY

10.1. Europe Atrial Fibrillation Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Europe Atrial Fibrillation Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. UK
         10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4. Germany
         10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5. France
         10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.6. Spain
         10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.7. Rest of Europe
         10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 11. ASIA-PACIFIC ATRIAL FIBRILLATION DRUGS MARKET BY COUNTRY

11.1. Asia-Pacific Atrial Fibrillation Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Asia-Pacific Atrial Fibrillation Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. China
         11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4. Japan
         11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5. India
         11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.6. Australia
         11.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.7. South Korea
         11.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.8. Rest of Asia-Pacific
         11.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.8.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 12. LATIN AMERICA ATRIAL FIBRILLATION DRUGS MARKET BY COUNTRY

12.1. Latin America Atrial Fibrillation Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Latin America Atrial Fibrillation Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Brazil
         12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         12.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4. Argentina
         12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         12.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5. Rest of Latin America
         12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         12.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 13. MIDDLE EAST ATRIAL FIBRILLATION DRUGS MARKET BY COUNTRY

13.1. Middle East Atrial Fibrillation Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Middle East Atrial Fibrillation Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. Saudi Arabia
         13.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         13.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
13.4. UAE
         13.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         13.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
13.5. Rest of Middle East
         13.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         13.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 14. AFRICA ATRIAL FIBRILLATION DRUGS MARKET BY COUNTRY

14.1. Africa Atrial Fibrillation Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
14.2. Africa Atrial Fibrillation Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
14.3. South Africa
         14.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         14.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
14.4. Egypt
         14.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         14.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
14.5. Rest of Africa
         14.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         14.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 15. COMPANY PROFILE

15.1. Johnson & Johnson
         15.1.1. Company Snapshot
         15.1.2. Overview
         15.1.3. Financial Overview
         15.1.4. Product Portfolio
         15.1.5. Key Developments
         15.1.6. Strategies
15.2. Pfizer
         15.2.1. Company Snapshot
         15.2.2. Overview
         15.2.3. Financial Overview
         15.2.4. Product Portfolio
         15.2.5. Key Developments
         15.2.6. Strategies
15.3. Sanofi
         15.3.1. Company Snapshot
         15.3.2. Overview
         15.3.3. Financial Overview
         15.3.4. Product Portfolio
         15.3.5. Key Developments
         15.3.6. Strategies
15.4. Bayer AG
         15.4.1. Company Snapshot
         15.4.2. Overview
         15.4.3. Financial Overview
         15.4.4. Product Portfolio
         15.4.5. Key Developments
         15.4.6. Strategies
15.5. Boehringer Ingelheim
         15.5.1. Company Snapshot
         15.5.2. Overview
         15.5.3. Financial Overview
         15.5.4. Product Portfolio
         15.5.5. Key Developments
         15.5.6. Strategies
15.6. Bristol-Myers Squibb
         15.6.1. Company Snapshot
         15.6.2. Overview
         15.6.3. Financial Overview
         15.6.4. Product Portfolio
         15.6.5. Key Developments
         15.6.6. Strategies
15.7. Daiichi Sankyo
         15.7.1. Company Snapshot
         15.7.2. Overview
         15.7.3. Financial Overview
         15.7.4. Product Portfolio
         15.7.5. Key Developments
         15.7.6. Strategies
15.8. AstraZeneca
         15.8.1. Company Snapshot
         15.8.2. Overview
         15.8.3. Financial Overview
         15.8.4. Product Portfolio
         15.8.5. Key Developments
         15.8.6. Strategies
15.9. Others
         15.9.1. Company Snapshot
         15.9.2. Overview
         15.9.3. Financial Overview
         15.9.4. Product Portfolio
         15.9.5. Key Developments
         15.9.6. Strategies

CHAPTER 16. RESEARCH APPROACH

16.1. Research Methodology
         16.1.1. Initial Data Search
         16.1.2. Secondary Research
         16.1.3. Primary Research
16.2. Assumptions and Scope

Cart Summary